Ultragenyx Pharmaceutical annual debt-to-equity ratio
2019
2020
2021
2022
2023
2024
Ultragenyx Pharmaceutical Debt-to-Equity Ratio Growth & History (RARE)
Ultragenyx Pharmaceutical's debt-to-equity ratio was 0.16 for fiscal 2024.
View full Ultragenyx Pharmaceutical company overviewUltragenyx Pharmaceutical annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.16 | 0.00 | +0.77% |
| 2023 | 2023-12-31 | 0.16 | 0.07 | +74.90% |
| 2022 | 2022-12-31 | 0.09 | 0.04 | +97.29% |
| 2021 | 2021-12-31 | 0.05 | 0.00 | +8.89% |
| 2020 | 2020-12-31 | 0.04 | −0.01 | −26.17% |
| 2019 | 2019-12-31 | 0.06 | — | — |
Ultragenyx Pharmaceutical quarterly debt-to-equity ratio
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | 3.69 | — | — |
| Q2 2025 | 2025-06-30 | 0.24 | — | — |
| Q1 2025 | 2025-03-31 | 0.27 | — | — |
| Q4 2024 | 2024-12-31 | 0.16 | 0.00 | +0.77% |
| Q4 2023 | 2023-12-31 | 0.16 | 0.07 | +74.90% |
| Q4 2022 | 2022-12-31 | 0.09 | 0.04 | +97.29% |
| Q4 2021 | 2021-12-31 | 0.05 | 0.00 | +8.89% |
| Q4 2020 | 2020-12-31 | 0.04 | −0.01 | −26.17% |
| Q3 2020 | 2020-09-30 | 0.07 | −0.03 | −30.38% |
| Q2 2020 | 2020-06-30 | 0.06 | −0.03 | −29.60% |
| Q1 2020 | 2020-03-31 | 0.07 | 0.01 | +20.61% |
| Q4 2019 | 2019-12-31 | 0.06 | — | — |
| Q3 2019 | 2019-09-30 | 0.10 | — | — |
| Q2 2019 | 2019-06-30 | 0.09 | — | — |
| Q1 2019 | 2019-03-31 | 0.06 | — | — |
Ultragenyx Pharmaceutical debt-to-equity ratio trends
Over the last five fiscal years, Ultragenyx Pharmaceutical's debt-to-equity ratio increased from 0.06 to 0.16, a change of 0.10. The latest reported quarter, Q3 2025, shows 3.69.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ultragenyx Pharmaceutical source filings ↗